,
your personalized virtual assistant to find clinical trials. Go head, 
James L. Wade, MD
Sherman HospitalElgin, Illinois - 60123 (217-876-6617) |
- CLINICAL TRIALS 5
- CONDITIONS5
- INTERVENTIONS23
- SINCE2003
Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer
November 2003 - June 2012
Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
July 2009 - February 2012
Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013
Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery
November 2008 - August 2009
Breast Neoplasms
Lung Neoplasms
Lymphoma
Carcinoma, Non-Small-Cell Lung
Hodgkin Disease
Placebo
Filgrastim
Fludeoxyglucose F 18
Paclitaxel
Bevacizumab
Cisplatin
Gemcitabine Hydrochloride
Cyclophosphamide
Prednisone
Doxorubicin Hydrochloride
Etoposide
Vincristine Sulfate
Vinblastine Sulfate
Trastuzumab
Ixabepilone
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Dacarbazine
Ac Regimen
Bleomycin Sulfate
Abvd Regimen
Beacopp Regimen
Procarbazine Hydrochloride
Active Surveillance
